Kansas Spine and Specialty Hospital

NextStage Clinical Research

Acute Pain

Intervertebral Disc Degeneration

Postoperative Pain

VX-548

epinephrine

Bupivacaine

Vertex Pharmaceuticals

Heron Therapeutics

Kuros Biosciences

condition

allSponsorName

Avania

gender

Male

Female

overallStatus

Recruiting

Not yet recruiting

Active, not recruiting

Enrolling by invitation

Completed

Terminated

Withdrawn

Suspended

Unknown

type

Interventional

Observational

Expanded Access

phase

Early Phase 1

Phase 1

Phase 2

Phase 3

Phase 4

Not Applicable

funderTypes

Industry

Other U.S. Federal agency

All others

ageGroup

Child (birth-17)

Adult (18-64)

Older Adult (65+)

The purpose of this study is to evaluate the safety and efficacy of KUR-113 Bone Graft (TGplPTH1-34 in fibrin) compared to local autograft for the treatment of Degenerative Disk Disease (DDD).

KUR-113 Bone Graft Versus Local Autograft for the Treatment of Single-level Transforaminal Lumbar Interbody Fusion

NextStage Clinical Research | Kansas Spine and Specialty Hospital

Site insights

Work at this site?

Active trials

KUR-113 Bone Graft Versus Local Autograft for the Treatment of Single-level Transforaminal Lumbar Interbody Fusion (STRUCTURE)

Trial sponsors